Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

In the Wake of the Opioid Epidemic, Multi Radiance Medical Introduces the Next Generation of Non-Invasive, Drug-Free Pain Relief

Drugs and prescription opioids have reached epidemic status in the United States, killing more Americans than car accidents. More and more, patients and clinicians are becoming aware of the need for more effective, less harmful alternatives; enter the laser.


News provided by

Multi Radiance Medical

Aug 15, 2018, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Laser therapy has been proven to treat a wide range of medical conditions
Laser therapy has been proven to treat a wide range of medical conditions

CLEVELAND, Aug. 15, 2018 /PRNewswire-PRWeb/ -- The awful reality is that drugs and prescription opioids have reached epidemic status in the United States, killing more Americans than car accidents. Nearly 250 billion opioid prescriptions for pain relief were written in 2013. A CDC study indicates that 1 in 6 working Americans have pain every day.

It's a vicious cycle; with long-term use, the body develops an opioid tolerance and people start taking stronger doses just to get the same pain relief effect. Taking stronger doses leads to the potential risk of addiction and overdose.

The FDA has cleared low level laser therapy, with over 400 randomized, double-blind, placebo-controlled trials that have been published, making it a validated alternative for people seeking pain relief without having surgery or taking drugs.

Post this

Even over-the-counter pain medications and NSAIDs like aspirin, acetaminophen and ibuprofen can have potentially dangerous side effects like increased risk of heart attack or gastrointestinal issues. Moreover, over-the-counter pain medications aren't meant to treat chronic (long-lasting) pain. In the case of chronic pain from arthritis, people assume the pain medication will treat arthritis, making it better, but in reality it only helps temporarily relieve pain and discomfort.

More and more, Americans are becoming aware of the need for more effective, less harmful alternatives to opioids and over-the-counter pain medications.

Enter the laser.

The theoretical foundations of the laser were proposed by Albert Einstein in the early 1900s, but it wasn't until 1967 when Dr. Endre Mester first used low level laser for therapeutic purposes. Early on, it was noted that low powers of laser were beneficial in managing pain and accelerated the body's ability to recover. These low doses of light provided non-invasive, non-drug pain relief while reducing inflammation and promoting injury repair.

The United States Food and Drug Administration (FDA) has cleared low level laser therapy (LLLT) for a number of conditions, making it a validated alternative for people seeking pain relief without having surgery or taking drugs.

Over 400 randomized, double-blind, placebo-controlled trials have been published, with over 4,000 laboratory studies of LLLT available on Pubmed.gov. Low level laser therapy has been proven to treat a wide range of medical conditions such as:

  • Muscle & joint pain
  • Stiffness associated with arthritis
  • Pain associated with muscle spasms
  • Hand/Wrist pain
  • Neck Pain
  • Lower Back Pain

In 2011, Jerry Lupia of North Carolina injured his back and could hardly move without assistance. After trying over-the-counter medicines and receiving adjustments from doctors with little results, he decided to try laser therapy after hearing professional football players were using it.

After five treatment sessions, his lower back pain subsided and he could move freely again. Since successfully relieving his back pain, he also received laser therapy treatment for knee pain which had prevented him from walking up the front steps to his house. With another five laser therapy sessions, he was completely pain-free.

"I've recommended it to many of my friends and I swear by it because it works," Lupia said. "I would be lost without laser therapy."

Treatment is easy. Just apply the laser over the painful area for 30 seconds to several minutes, depending on the condition being treated. The device can be held directly on the skin. Since the laser is low-powered, there is no risk of burns or overheating. A manual provides treatment directions, while a timer ensures the optimal treatment time.

Laser therapy has short-term and long-term effects. With even the first use, laser therapy can provide analgesic pain relief. The energy from the laser light fuels cellular activities that have become inefficient due to the injury. Adenosine triphosphate (ATP) or cell energy production is restored by removing nitric oxide (NO) from inside the mitochondria within our cells. This NO release improves blood flow, improving circulation and delivering oxygen to damaged tissues. Now, more energy and oxygen is available by the body to repair the damaged tissues.

More and more physicians are using laser therapy in their practices. Sol Cogan, DC, first saw the benefits of laser therapy as the team chiropractor for the Detroit Lions more than 15 years ago, and has been using laser in his practice ever since.

"Laser therapy is a great natural way to relieve pain and promote recovery," Dr. Cogan explained. "It's a great adjunct to our practice and we've seen great results in treating back pain, neck pain, and peripheral neuropathy with laser."

While many lasers are sold in the USA, only a select few like Multi Radiance Medical have received the FDA's NHN product classification, which designates Multi Radiance laser devices as non-thermal. This product classification is rare among laser manufacturers due to the very rigorous and expensive application process, which includes conducting and submitting clinical data to support the laser's claims of safety and effectiveness.

All lasers aren't alike – here's what to look for when shopping for your laser.

About Multi Radiance Medical
Multi Radiance Medical is a leading developer and manufacturer of FDA-cleared super pulsed laser therapy technology used for the temporary relief of acute/chronic pain, muscle stiffness, arthritis, muscle spasms, neck and shoulder pain, and other conditions. This medical technology has been the equipment of choice for 90 professional and collegiate sports teams along with U.S. and Canadian National teams. Multi Radiance technology is supported by nearly 30 scientific studies for superior clinical efficacy and safety.

SOURCE Multi Radiance Medical

Related Links

multiradiance.com

Modal title

Multi Radiance Medical 2018 Media Kit
View PDF
Multi Radiance Medical 2018 Media Kit
Multi Radiance Medical is a leading developer and manufacturer of FDA cleared super pulsed laser therapy technology
Multi Radiance Medical is a leading developer and manufacturer of FDA cleared super pulsed laser therapy technology
Multi Radiance Medical 2018 Media Kit Multi Radiance Medical is a leading developer and manufacturer of FDA cleared super pulsed laser therapy technology

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.